The Golden State Warriors are considering trading Kristaps Porziņģis amid ongoing health concerns linked to his diagnosis of postural orthostatic tachycardia syndrome (POTS), according to ESPN. This development emerges just hours before the Warriors' season opener against the Los Angeles Lakers on Wednesday night.
The Warriors issued a statement on Wednesday addressing the situation but declined to comment on trade speculation or Porziņģis’s health status. "We are not going to comment on trade speculation or reports regarding his health-related matter or future," the team said. They added, "As noted last week, conversations between the Warriors, Kristaps and his representatives will remain private. We are not anticipating Kristaps being around the team in the immediate future. We'll provide additional updates when available and appropriate."
This statement follows last week’s update when the Warriors said Porziņģis would be out indefinitely but "will be around the team." However, the current message suggests a more uncertain outlook regarding his availability and role with the squad.
Porziņģis re-signed with Golden State this summer on a two-year, $40 million deal, which includes a $20 million salary for the 2026-27 season and a $3 million guarantee for 2027-28. He joined the Warriors at the trade deadline last season in a deal with the Atlanta Hawks but appeared in only 15 games, averaging 16.1 points and 5.3 rebounds during that stretch.
Golden State had hoped Porziņģis would strengthen their frontcourt depth this season, but his health issues have kept him sidelined through training camp and the preseason. Both Porziņģis and the Warriors released statements last week providing a vague update. Porziņģis said he was feeling better and aimed to return to play soon, while denying various rumors about his condition. The Warriors noted he had met with the front office and medical staff but offered no timeline for his return.
The current situation indicates the Warriors may doubt Porziņģis’s ability to contribute this season. His ongoing health challenges raise questions about how reliable he will be for a team aiming for a playoff push in the competitive Western Conference.
Finding a trade partner for Porziņģis appears complicated. His contract was structured to facilitate a move if necessary, but the uncertainty surrounding his health makes the deal less attractive. The Warriors have positioned themselves for flexibility next offseason, including a contract extension with Stephen Curry that leaves room for pursuing star players in 2027. This means Golden State is unlikely to absorb long-term salary in a Porziņģis trade.
If the Warriors pursue a trade, they may need to include valuable assets to convince another team to take on Porziņģis’s expiring contract. Any incoming player would need to offer immediate rotation value to justify such a deal.
Porziņģis’s situation remains fluid, with no confirmed timetable for his return or clarity on his future with the Warriors. The team’s cautious approach and private discussions with the player and his representatives suggest a delicate balance between managing his health and the team’s competitive goals.
According to CBS.
